Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of Trigeminal Neuralgia~* Male; or non-pregnant/non-lactating female~* Must be willing to cooperate with and understands study instructions~* Signed informed consent prior to entering study~Exclusion Criteria:~* psychiatric illness~* severe liver or cardiovascular disease~* renal impairment, low white cell count~* malignancy~* pregnancy or lactation~* alcohol or recreational drug abuse~* and positive tests for human immunodeficiency virus or hepatitis B or C.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lamictal® (Type: EXPERIMENTAL): Lamictal® was used as the active medication in this study.
- Tegretol® (Type: ACTIVE_COMPARATOR): Tegretol® was employed as the control for comparative purposes in order to check and evaluate the efficacy (pain-relief) and occurrence of side- effects of Lamictal®.

Based on this trial design, predict the completion outcome and termination type (if applicable).